Jun joined the Cancer Research Institute in January 2017 as a senior research analyst in the Institute’s Clinical Accelerator program, where he is using his scientific training to help accelerate the translation of new cancer immunotherapy combinations from labs to the clinic.
Prior to CRI, Jun spent more than a decade as a scientist in immunology and biomedical engineering. He received his bachelor degree in bioengineering in 2005 and a master degree in biochemistry in 2008 in China. After that, he moved to the U.S. and received his Ph.D. in 2014 from Icahn School of Medicine at Mount Sinai, where he developed nanomaterial-based immunotherapies for cardiovascular diseases and cancer. He then pursued a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in 2015, where he developed cancer immunotherapies for solid tumors and imaging probes for nuclear oncological imaging. Jun has published more than 28 peer-reviewed papers, given over ten conference presentations, won eight research awards, and filed one patent.
Jun strongly believes that cancer immunotherapy will revolutionize cancer treatment and save millions of lives.
- Tang J, Shalabi A, Hubbard-Lucey VM. Comprehensive analysis of the clinical immuno-oncology landscape. Ann Oncol. 2017 Dec 7. doi: 10.1093/annonc/mdx755. [Epub ahead of print]
- Tang J, Salloum D, Carney B, et al. Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 114 E7441-7449 (2017).
- Hogstad B*, Berres M*, Chakraborty R*, Tang J, et al. RAF/MEK/ERK pathway suppresses dendritic cell migration and traps dendritic cells in LCH lesions. J Exp Med, In Press, (2017).
- Tang J, Baxter S, Menon A, et al., Immune cell screening of a nanoparticle library improves atherosclerosis therapy. Proc Natl Acad Sci USA 113, E6731-E6740 (2016).
- Perez-Medina C, Abdel-Atti D, Tang J, et al., Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nature communications 7, 11838 (2016).
- Tang J, Lobatto ME, Hassing L, et al., Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Science Advances 1, (2015).
- Perez-Medina C, Tang J, Abdel-Atti D, et al., PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. J Nucl Med 56, 1272-1277 (2015).
- Duivenvoorden R*, Tang J*, Cormode DP, et al., A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nature Communications 5, 3065 (2014).
- Gianella A, Jarzyna PA, Mani V, Ramachandran S, Calcagno C, Tang J, et al., Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 5, 4422-4433 (2011).
Let's spread the word about Immunotherapy! Click to share this page with your community.